Related Experiment Video
Updated: Oct 3, 2025

Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study
Published on: July 7, 2023
Emerging Roles of m6A RNA Methylation Regulators in Gynecological Cancer
Wanjun Huang1, Fanhua Kong2, Ruolan Li1
1Department of Obstetrics and Gynecology, Taizhou Central Hospital (Taizhou University, Hospital), Taizhou, China.
Abstract:
Gynecological cancers seriously affect the reproductive system of females; diseases include ovarian tumors, uterine tumors, endometrial cancers, cervical cancers, and vulva and vaginal tumors. At present, the diagnosis methods of gynecological cancer are insufficiently sensitive and specific, leading to failure of early disease detection. N6-methyladenosine (m6A) plays various biological functions in RNA modification and is currently studied extensively. m6A modification controls the fate of transcripts and regulates RNA metabolism and biological processes through the interaction of m6A methyltransferase ("writer") and demethylase ("erasers") and the binding protein decoding m6A methylation ("readers"). In the field of epigenetics, m6A modification is a dynamic process of reversible regulation of target RNA through its regulatory factors. It plays an important role in many diseases, especially cancer. However, its role in gynecologic cancers has not been fully investigated. Thus, we review the regulatory mechanism, biological functions, and therapeutic prospects of m6A RNA methylation regulators in gynecological cancers.
Insights
N6-methyladenosine (m6A) RNA modification is crucial in cancer. This review explores m6A regulators
Area of Science:
- Epigenetics and Molecular Biology
- Oncology
- Gynecology
Background:
- Gynecological cancers pose significant health risks to females, with current diagnostic methods lacking sensitivity and specificity for early detection.
- N6-methyladenosine (m6A) is a key RNA modification involved in various biological functions, including cancer development.
- The role of m6A RNA methylation regulators in gynecological cancers remains underexplored.
Approach:
- This review synthesizes current research on m6A RNA methylation.
- It examines the regulatory mechanisms, biological functions, and therapeutic potential of m6A regulators in gynecological malignancies.
- The review focuses on the interplay between m6A 'writers,' 'erasers,' and 'readers' in cancer progression.
Key Points:
- m6A modification is a dynamic epigenetic process regulating RNA metabolism and gene expression.
- Dysregulation of m6A regulators is implicated in various cancers, including gynecological cancers.
- Understanding m6A pathways offers potential for novel diagnostic and therapeutic strategies.
Conclusions:
- m6A RNA methylation plays a critical role in the pathogenesis of gynecological cancers.
- Targeting m6A regulators presents promising therapeutic avenues for improving patient outcomes.
- Further investigation into m6A mechanisms is warranted for clinical translation in gynecologic oncology.
Related Concept Videos
Epigenetic Regulation
MicroRNAs
Master Transcription Regulators
RNA Stability
Regulation of Expression at Multiple Steps
The Nucleolus

